ArticleDrug design, development and therapy2025

Targeting CD20 in Primary Membranous Nephropathy Serologically and Histologically Negative for PLA2R: Is Obinutuzumab Superior to Rituximab?

Huiling Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.